What is OrthAlign?
OrthAlign provides advanced computer-assisted surgery technology to orthopedic surgeons, focusing on precise alignment during hip and knee replacement procedures. Their proprietary Lantern platform supports a range of arthroplasties, including total hip, total knee, revision knee, and partial knee procedures. The company's mission is to democratize access to empowering healthcare technologies, ensuring high-quality patient care through user-friendly and cost-effective solutions suitable for any surgical environment. OrthAlign's commitment to innovation positions it as a key player in the medtech industry, aiming to enhance surgical outcomes and operational efficiency.
How much funding has OrthAlign raised?
OrthAlign has raised a total of $37.2M across 5 funding rounds:
Series A
$7.2M
Private Equity
$4M
Series C
$15M
Series D
$10M
Debt
$1M
Series A (2009): $7.2M with participation from Research Corporation
Private Equity (2010): $4M, investors not publicly disclosed
Series C (2014): $15M supported by River Cities Capital Funds and Mutual Capital Partners Funds
Series D (2017): $10M featuring Research, Mutual Capital Partners, River Cities Capital Funds, and California Technology Ventures, LLC
Debt (2020): $1M backed by PPP
Key Investors in OrthAlign
Research
Research Corp is an entity operating within the Research & Development industry, likely contributing to OrthAlign's technological advancements and innovation pipeline.
Mutual Capital Partners
Mutual Capital Partners is a venture capital fund specializing in early-stage software and medical device companies, providing financial backing and strategic guidance to innovative healthcare startups.
River Cities Capital Funds
River Cities Capital Funds is a growth equity firm focused on building high-potential healthcare companies, particularly in medical devices, healthcare services, and healthcare IT, aiming to enhance patient outcomes and care delivery.
What's next for OrthAlign?
With the recent influx of major strategic investment and a substantial overall funding history of $37.2M, OrthAlign is poised for accelerated growth and market penetration. The company's focus on developing accessible and precise surgical alignment technology suggests a strategic direction towards expanding its product suite and increasing adoption across a wider range of healthcare facilities. Future developments may include further integration of AI and data analytics into their surgical platforms, enhancing surgeon capabilities and patient recovery. The company's continued pursuit of innovation in orthopedic surgery technology indicates a strong potential for market leadership and significant impact on patient care.
See full OrthAlign company page
